P2X3 antisense oligonucleotides (Neuromics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameP2X3 antisense oligonucleotides (Neuromics)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionP2X purinoceptor 3 antagonists
TargetsP2X purinoceptor 3
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuromics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuromics Inc
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A